Srinivas Nanduri

3.2k total citations
114 papers, 2.5k citations indexed

About

Srinivas Nanduri is a scholar working on Organic Chemistry, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Srinivas Nanduri has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Organic Chemistry, 67 papers in Molecular Biology and 16 papers in Complementary and alternative medicine. Recurrent topics in Srinivas Nanduri's work include Synthesis and biological activity (34 papers), Phenothiazines and Benzothiazines Synthesis and Activities (25 papers) and Cancer therapeutics and mechanisms (24 papers). Srinivas Nanduri is often cited by papers focused on Synthesis and biological activity (34 papers), Phenothiazines and Benzothiazines Synthesis and Activities (25 papers) and Cancer therapeutics and mechanisms (24 papers). Srinivas Nanduri collaborates with scholars based in India, Italy and United States. Srinivas Nanduri's co-authors include Srikanth Gatadi, Sriram Rajagopal, Y.V. Madhavi, Nitin Kumar, Sidharth Chopra, Sanjeev Kumar, Vinaykumar Kanchupalli, Saiprasad Nunewar, Jitendra Gour and Amitava Dasgupta and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Srinivas Nanduri

103 papers receiving 2.3k citations

Peers

Countries citing papers authored by Srinivas Nanduri

Since Specialization

Citations

This map shows the geographic impact of Srinivas Nanduri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Nanduri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Nanduri more than expected).

Fields of papers citing papers by Srinivas Nanduri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Nanduri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Nanduri. The network helps show where Srinivas Nanduri may publish in the future.

Co-authorship network of co-authors of Srinivas Nanduri

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Nanduri. A scholar is included among the top collaborators of Srinivas Nanduri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Nanduri. Srinivas Nanduri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indazole – an emerging privileged scaffold: synthesis and its biological significance 2025 ·RSC Medicinal Chemistry ·(unknown), Pardeep Kumar, (unknown), (unknown), Srinivas Nanduri, Venkata Madhavi Yaddanapudi	3
2	Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation 2025 ·ChemMedChem ·Pardeep Kumar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aman Dalal, (unknown), (unknown), Srinivas Nanduri, Nitin Pal Kalia, (unknown), Alessandro Bonardi, Paola Gratteri, (unknown), Venkata Madhavi Yaddanapudi	0
3	Transition metal-free one-pot tandem chemoselective reduction and cyclization of 3/5-(2-nitrophenyl)-1H-pyrazoles using sodium dithionite 2025 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Amol G. Dikundwar, Sidharth Chopra, Venkata Madhavi Yaddanapudi, Srinivas Nanduri	0
4	Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis β-carbonic anhydrases 2025 ·RSC Medicinal Chemistry ·(unknown), (unknown), (unknown), Pardeep Kumar, (unknown), (unknown), (unknown), Srinivas Nanduri, (unknown), Aman Dalal, Nitin Pal Kalia, Vasundhra Bhandari, Paola Gratteri, (unknown), Alessandro Bonardi, (unknown), Venkata Madhavi Yaddanapudi	0
5	Exploring spirocyclic isoquinoline-piperidine compounds in tuberculosis therapy: ADMET profiling, docking, DFT, MD simulations, and MMGBSA analysis 2025 ·Computational Biology and Chemistry ·(unknown), (unknown), (unknown), (unknown), Pardeep Kumar, Venkata Madhavi Yaddanapudi, Vasundhra Bhandari, Srinivas Nanduri, (unknown), (unknown), Ali Oubella	7
6	Exploration of Benzofuran/Indole‐Chalcone Conjugated 1,2,3‐Triazole Hybrids as Candida glabrata Agents: Design, Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Analysis 2025 ·Chemistry & Biodiversity ·(unknown), (unknown), Pardeep Kumar, (unknown), (unknown), (unknown), Srinivas Nanduri, Renu Shukla, Krishnaveni Mishra, Venkata Madhavi Yaddanapudi	2
7	Exploration of New Dihydroindazole Derivatives as Promising Anti‐TB Agents: Design, Synthesis, In Silico, and Biological Evaluation 2025 ·Archiv der Pharmazie ·Pardeep Kumar, (unknown), (unknown), Deepanshi Saxena, (unknown), (unknown), (unknown), (unknown), (unknown), Amol G. Dikundwar, Srinivas Nanduri, Amitava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi	1
8	Synthesis and antibacterial evaluation of new naphthalimide-coumarin hybrids against multidrug-resistant S. aureus and M. tuberculosis 2024 ·Journal of Molecular Structure ·(unknown), (unknown), (unknown), (unknown), Grace Kaul, (unknown), (unknown), Arnab Roy, (unknown), Deepanshi Saxena, (unknown), Y.V. Madhavi, Amitava Dasgupta, Nitin Pal Kalia, Narayana Nagesh, Sidharth Chopra, Srinivas Nanduri	6
9	Development of naphthalimide hydrazide derivatives as potent antibacterial agents against carbapenem-resistant A. baumannii 2024 ·RSC Medicinal Chemistry ·(unknown), (unknown), Deepanshi Saxena, (unknown), (unknown), (unknown), (unknown), (unknown), Vasundhra Bhandari, Y.V. Madhavi, Amitava Dasgupta, Sidharth Chopra, Srinivas Nanduri	1
10	New Indole‐Based Phenylthiazolyl‐2,4‐dihydropyrazolones as Tubulin polymerization inhibitors: Multicomponent Synthesis, Cytotoxicity Evaluation, and in silico Studies 2024 ·ChemMedChem ·(unknown), (unknown), (unknown), (unknown), (unknown), Srinivas Nanduri, Anamika Sharma, Chandraiah Godugu, Venkata Madhavi Yaddanapudi	3
11	Benzyl/phenyl‐1,2,3‐Triazole Tethered 3‐Acetyl Coumarins as Potential Drug‐Resistant Antitubercular Agents: Synthesis, Biology, and in Silico Investigations as Mtb DNA Gyrase Inhibitors 2024 ·ChemistrySelect ·(unknown), (unknown), (unknown), Shital Raut, (unknown), (unknown), Deepanshi Saxena, (unknown), (unknown), Nitin Pal Kalia, Srinivas Nanduri, Amitava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi	3
12	Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors 2023 ·Archiv der Pharmazie ·(unknown), Ravikumar Akunuri, Shaik Mahammad Ghouse, (unknown), Andrea Angeli, (unknown), Mohammed Arifuddin, Venkata Madhavi Yaddanapudi, Claudiu T. Supuran, Srinivas Nanduri	6
13	Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors 2023 ·Archiv der Pharmazie ·(unknown), (unknown), Alessandro Bonardi, Paola Gratteri, (unknown), (unknown), Srinivas Nanduri, Mohammed Arifuddin, Nitin Pal Kalia, Rajesh Sonti, Claudiu T. Supuran, Venkata Madhavi Yaddanapudi	8
14	Synthesis and biological evaluation of 1-phenyl-4,6-dihydrobenzo[b]pyrazolo[3,4-d]azepin-5(1H)-one/thiones as anticancer agents 2023 ·Bioorganic Chemistry ·(unknown), Ravikumar Akunuri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Venkata Madhavi Yaddanapudi, Manoj P. Dandekar, Velma Ganga Reddy, Narayana Nagesh, Srinivas Nanduri	16
15	Promising antibacterial agents against multidrug resistant Staphylococcus aureus 2019 ·Bioorganic Chemistry ·Srikanth Gatadi, Y.V. Madhavi, Sidharth Chopra, Srinivas Nanduri	44
16	Facile synthesis of 1,2,3-triazole-fused indolo- and pyrrolo[1,4]diazepines, DNA-binding and evaluation of their anticancer activity 2019 ·Bioorganic Chemistry ·Jitendra Gour, Srikanth Gatadi, Venkatesh Pooladanda, Shaik Mahammad Ghouse, Satyaveni Malasala, Y.V. Madhavi, Chandraiah Godugu, Srinivas Nanduri	32
17	Natural product derived promising anti-MRSA drug leads: A review 2019 ·Bioorganic & Medicinal Chemistry ·Srikanth Gatadi, Jitendra Gour, Srinivas Nanduri	32
18	Andrographolide: A natural product template for the generation of structurally and biologically diverse diterpenes 2019 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Srinivas Nanduri	62
19	Targeting AMPK in Diabetes and Diabetic Complications: Energy Homeostasis, Autophagy and Mitochondrial Health 2018 ·Current Medicinal Chemistry ·Y.V. Madhavi, (unknown), Veera Ganesh Yerra, Anil Kumar Kalvala, Srinivas Nanduri, Ashutosh Kumar	94
20	DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells 2004 ·BMC Cancer ·Chitkala Satyanarayana, (unknown), Rukkumani Rajagopalan, Srinivas Nanduri, Sriram Rajagopal	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact